16 employees
IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state kidney disease (ESKD).
2013
IVIVA Medical Inc raised undisclosed on March 5, 2021
Investors: Thynk Capital and Bioverge
IVIVA Medical Inc raised undisclosed on March 1, 2018
Investors: BOLD Capital Partners